Tuberculosis has plagued humanity for thousands of years, and despite medical advances that can now help us prevent and cure it, the ancient bacterial disease still claims more human lives per year ...

An early view of the immune response to bacteria in the lungs provides clues as to why some people keep TB in check, while ...

A new intranasal DNA vaccine may give the immune system an extra weapon against tuberculosis by targeting bacteria that can ...

Across the spectrum of human afflictions—from cancer to heart disease to rare genetic conditions—medical investigators are continually attempting to break new ground by developing better methods of ...

Tuberculosis (TB) is one of the world's most common infectious diseases. Although infection with the Mycobacterium tuberculosis bacterium primarily affects the lungs, up to 25% of all infected people ...

Researchers used 6MWD to assess the association between physical function and the effectiveness of ART and anti-tubercular therapy in patients with HIV/TB co-infection. In patients with TB/HIV, higher ...

An experimental drug now in clinical trials as a cancer treatment could help boost the power of first-line tuberculosis (TB) treatments by helping infected cells die a gentler death, investigators ...

A history of tuberculosis (TB) and a history of chronic bronchitis were associated with an increased risk for lung cancer in individuals who had never smoked, whereas asthma had a positive, ...

Nearly half of lung cancer patients die after being misdiagnosed with tuberculosis. Many clinicians, research has revealed, put patients with these symptoms; coughing, weight loss and shortness of ...